Marina Bagnoli

2.9k total citations
50 papers, 2.1k citations indexed

About

Marina Bagnoli is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Marina Bagnoli has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Marina Bagnoli's work include Ovarian cancer diagnosis and treatment (15 papers), MicroRNA in disease regulation (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Marina Bagnoli is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), MicroRNA in disease regulation (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Marina Bagnoli collaborates with scholars based in Italy, United States and China. Marina Bagnoli's co-authors include Delia Mezzanzanica, Silvana Canevari, Giuseppe Toffoli, Antonio Russo, C. Cernigoi, Mauro Boiocchi, Angelo Gallo, Silvia Miotti, Antonella Tomassetti and Egidio Iorio and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Marina Bagnoli

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Bagnoli Italy	25	1.2k	631	623	306	260	50	2.1k
Dorina Belotti Italy	26	1.3k 1.0×	897 1.4×	779 1.3×	213 0.7×	186 0.7×	43	2.4k
Oliver Dorigo United States	28	971 0.8×	710 1.1×	205 0.3×	473 1.5×	347 1.3×	89	2.2k
Patrizia Borsotti Italy	26	1.7k 1.4×	868 1.4×	1.0k 1.6×	291 1.0×	83 0.3×	33	2.9k
Rosemary Foster United States	29	1.7k 1.4×	1.6k 2.5×	649 1.0×	469 1.5×	440 1.7×	46	3.1k
Imayavaramban Lakshmanan United States	27	1.5k 1.2×	961 1.5×	407 0.7×	504 1.6×	70 0.3×	43	2.2k
Venkatesh Krishnan United States	20	1.1k 0.9×	758 1.2×	285 0.5×	961 3.1×	149 0.6×	35	2.3k
Sanaz Memarzadeh United States	23	1.1k 0.9×	918 1.5×	424 0.7×	345 1.1×	509 2.0×	60	2.3k
Gregory J. Riggins United States	21	1.0k 0.8×	432 0.7×	326 0.5×	116 0.4×	136 0.5×	35	1.9k
Junya Yoneda Japan	19	1.0k 0.8×	832 1.3×	562 0.9×	257 0.8×	151 0.6×	28	1.8k
Xin He China	27	1.3k 1.1×	456 0.7×	576 0.9×	500 1.6×	142 0.5×	132	2.4k

Countries citing papers authored by Marina Bagnoli

Since Specialization

Citations

This map shows the geographic impact of Marina Bagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Bagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Bagnoli more than expected).

Fields of papers citing papers by Marina Bagnoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Bagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Bagnoli. The network helps show where Marina Bagnoli may publish in the future.

Co-authorship network of co-authors of Marina Bagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Bagnoli. A scholar is included among the top collaborators of Marina Bagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Bagnoli. Marina Bagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Distefano, Rosario, Luisa Tomasello, Gian Luca Rampioni Vinciguerra, et al.. (2022). Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer. Cancer Research. 82(20). 3687–3700. 7 indexed citations

Bagnoli, Marina, et al.. (2022). Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer. Frontiers in Oncology. 12. 923508–923508. 5 indexed citations

Corno, Cristina, Pádraig D’Arcy, Marina Bagnoli, et al.. (2022). The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis. Frontiers in Cell and Developmental Biology. 10. 1055067–1055067. 10 indexed citations

Cecco, Loris De, Marina Bagnoli, Paolo Chiodini, Sandro Pignata, & Delia Mezzanzanica. (2021). Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets. Cancers. 13(7). 1544–1544. 7 indexed citations

Ditto, Antonino, Loris De Cecco, Biagio Paolini, et al.. (2021). Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment. European Journal of Cancer. 161. 55–63. 4 indexed citations

Cavalleri, A, Alessandra Napoli, Francesco Raspagliesi, et al.. (2021). Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells. Journal of Experimental & Clinical Cancer Research. 40(1). 5–5. 12 indexed citations

Bagnoli, Marina, Tingyan Shi, Charlie Gourley, et al.. (2019). Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions. Cells. 8(3). 200–200. 6 indexed citations

Dugo, Matteo, Loris De Cecco, Erika Cecchin, et al.. (2019). Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study. Genes. 10(9). 678–678. 9 indexed citations

Cecco, Loris De, Francesco Raspagliesi, Maria Luisa Carcangiu, et al.. (2018). Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth. Journal of Experimental & Clinical Cancer Research. 37(1). 146–146. 21 indexed citations

10.

Sun, Yan, Fei Guo, Marina Bagnoli, et al.. (2015). Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer. Chinese Journal of Cancer. 34(1). 28–40. 25 indexed citations

11.

Nicoletti, Roberta, Paola Perego, Egidio Iorio, et al.. (2015). Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma. Oncotarget. 6(13). 11216–11230. 20 indexed citations

12.

Carbotti, Grazia, Gaia Barisione, Anna Maria Orengo, et al.. (2013). The IL-18 Antagonist IL-18–Binding Protein Is Produced in the Human Ovarian Cancer Microenvironment. Clinical Cancer Research. 19(17). 4611–4620. 37 indexed citations

13.

Nicoletti, Roberta, Loris De Cecco, Maria Elena Pisanu, et al.. (2013). Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer. British Journal of Cancer. 110(2). 330–340. 46 indexed citations

14.

Carbotti, Grazia, Anna Maria Orengo, Delia Mezzanzanica, et al.. (2012). Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors. International Journal of Cancer. 132(11). 2597–2605. 41 indexed citations

15.

Bagnoli, Marina, Federico Ambrogi, Silvana Pilotti, et al.. (2009). c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome. Endocrine Related Cancer. 16(2). 443–453. 17 indexed citations

16.

Violini, Stefania, Sandra D’Ascenzo, Marina Bagnoli, et al.. (2004). Induction of a multifactorial resistance phenotype by high paclitaxel selective pressure in a human ovarian carcinoma cell line.. PubMed. 23(1). 83–91. 7 indexed citations

17.

Figini, Mariangela, Renata Ferri, Delia Mezzanzanica, et al.. (2003). Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. Gene Therapy. 10(12). 1018–1025. 55 indexed citations

18.

Bagnoli, Marina, Antonella Tomassetti, Mariangela Figini, et al.. (2000). Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to α-folate receptor overexpression. Oncogene. 19(41). 4754–4763. 73 indexed citations

19.

Miotti, Silvia, Marina Bagnoli, Francesca Ottone, et al.. (1997). Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. Journal of Cellular Biochemistry. 65(4). 479–491. 49 indexed citations

20.

Fıcı, Francesco, E Camarri, Francesca Galluzzi, & Marina Bagnoli. (1976). Evaluation of choleretic activity of dihydroxydibutyl ether.. PubMed. 20(6). 772–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact